ReviewFrontiers in pharmacology2020
Therapeutic Agents for the Treatment of Temporomandibular Joint Disorders: Progress and Perspective.
Review in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04811495 (Effectiveness of a Physiotherapy Treatment for Temporomandibular Hyperlaxity), which is not on this map. Cited by 24 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effectiveness of a Physiotherapy Treatment for Temporomandibular Hyperlaxity: a Case Report.
Who cites it
24 citing papers in PubMed, 5 syntheses or guidelines pooled it, 49 citations in OpenAlex.
- The efficacy of anterior repositioning splints in the management of temporomandibular disc displacement: a systematic review and meta-analysis.BMC oral health · 2025Pooled it
- Antinociceptive Efficacy of Shamanic Healing for the Management of Temporomandibular Disorders: An Evidence-Based Review.Journal of religion and health · 2024Pooled it
- Pharmacological therapy in the management of temporomandibular disorders and orofacial pain: a systematic review and meta-analysis.BMC oral health · 2024Pooled it
- Pooled it
- Pooled it
- Review
- The effect of self-mobilization in combination with exercises on pain and function in patients with myogenic temporomandibular disorders; a self-controlled experimental study.BMC oral health · 2026Article
- Percutaneous Drug Delivery to the Masticatory System: A Systematic Review and Analysis of Randomized Clinical Trials.Biomedicines · 2025Review
- Preclinical perspectives on disorders of the temporomandibular joint: Tracing the past, navigating the present, and shaping the future.The journal of pain · 2025Review
- Pharmacological and non-pharmacological approaches to temporomandibular disorder chronic pain: a narrative review.Pain management · 2025Review
- The Therapeutic Potential of Cannabidiol in the Management of Temporomandibular Disorders and Orofacial Pain.Pharmaceutics · 2025Review
- Temporomandibular Disorder Treatment With Diathermy Stimulation Technique: A Pilot Study.International journal of dentistry · 2025Article
- Nutritional Strategies for Chronic Craniofacial Pain and Temporomandibular Disorders: Current Clinical and Preclinical Insights.Nutrients · 2024Review
- A Comprehensive Analysis of the Efficacy of Injectable Medications in Relieving Temporomandibular Joint Discomfort: A Systematic Review.Journal of clinical practice and research · 2024Review
- Hyaluronic Acid-Based Microparticles with Lubrication and Anti-Inflammation for Alleviating Temporomandibular Joint Osteoarthritis.Biomaterials research · 2024Article
- Efficacy of the transcutaneous electrostimulation in treatment dysfunctions of the TMJ associated with occlusion distortions.BMC oral health · 2023Article
- Enhancing Pain Relief in Temporomandibular Joint Arthrocentesis: Platelet-Rich Plasma and Hyaluronic Acid Synergy.Cureus · 2023Review
- Novel Diagnostic and Therapeutic Approaches to Temporomandibular Dysfunction: A Narrative Review.Life (Basel, Switzerland) · 2023Review
- Article
- Diagnosis and Treatment of Myogenous Temporomandibular Disorders: A Clinical Update.Diagnostics (Basel, Switzerland) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Temporomandibular joint disorders (TMD) are a common health condition caused by the structural or functional disorders of masticatory muscles and the temporomandibular joint (TMJ). Abnormal mandibular movement in TMD patients may cause pain, chronic inflammation, and other discomfort, which could be relieved by a variety of drugs through various delivery systems. In this study, we summarized commonly used therapeutic agents in the management of TMD as well as novel bioactive molecules in preclinical stage and clinical trials. The emerging therapy strategies such as novel intra-TMJ delivery systems and implants based on tissue engineering are also discussed. This comprehensive review will strengthen our understanding of pharmacological approaches for TMD therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.